NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2023-05-09
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-03-31 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-03-31 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 0.00% 10-K · filed 2023-02-24 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-02-24 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 0.00% 10-K · filed 2023-02-24 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-07-31 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-04-29 | |||
| 2019-12-31 | 0.00% 10-K · filed 2022-02-25 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | 0.00% 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-06 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | 0.00% 10-K · filed 2020-02-28 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 0.00% 10-K · filed 2019-02-26 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-07 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-05 | |||
| 2015-12-31 | 0.00% 10-K · filed 2018-03-13 | |||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-14 | |||
| 2013-12-31 | 0.00% 10-K · filed 2016-04-18 | |||
| 2012-12-31 | 0.00% 10-K · filed 2015-03-03 | |||
| 2011-12-31 | 0.00% 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |